Artha Sootra - Company Dashboard

Governance Classic Home

Alembic Pharmaceuticals LtdPharmaceuticalsINE901L01018Consolidated₹906.70+103.90 (+12.94%)

Valuation

Market Cap₹17.82K Cr

TTM PE21.13x

Forward PE18.81x

PEG0.97

Book Value₹288.70

P/B3.14x

TTM EPS₹42.92

Fwd EPS₹48.21

TTM Revenue₹8.48K Cr

TTM PAT₹839.76 Cr

TTM EBITDA₹1.42K Cr

TTM EBIT₹1.05K Cr

Last Qtr PAT₹333.91 Cr

Last Qtr EBITDA₹563.26 Cr

Last Qtr EBIT₹462.46 Cr

Profitability

ROE14.80%

ROCE14.83%

TTM NPM9.91%

TTM EBITDA %16.71%

Curr OPM12.75%

Last OPM7.96%

Curr NPM—

Last NPM—

Curr EPS₹17.05

Last EPS₹8.80

Balance sheet

Equity₹39.31 Cr

Reserve₹5.64K Cr

Total Debt₹1,429.94 Cr

D/E0.25x

Interest %11.46%

Curr Interest₹38.26 Cr

Price / range

Close₹906.70

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+12.94%

1W+15.83%

1M+11.22%

3M+12.02%

6M+18.41%

1Y-5.56%

2Y-19.38%

3Y+24.81%

5Y+16.53%

Diwali+8.17%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	2,391.65+33.1%	1,868.06	1,718.74	1,642.24	1,796.24	6,651.38
Other Income	24.42	14.04	25.88	10.73	11.49	55.90
Total Income	2,416.07+33.7%	1,882.10	1,744.62	1,652.97	1,807.73	6,707.28
Interest	26.67	21.41	19.42	21.65	22.81	86.51
Expenditure	-1,881.26-18.2%	-1,626.20	-1,546.40	-1,471.96	-1,591.38	-5,986.18
PBDT	0	0	0	0	0	0
EBITDA	621.47+104.9%	345.81	274.07	271.60	303.31	1,062.71
Depreciation	-84.41	-82.54	-82.31	-79.67	-75.64	-311
EBIT	537.06+135.9%	263.27	191.76	191.93	227.67	751.71
PBT	534.81+147.2%	255.90	173.46	138.78	216.35	654.11
Tax	-125.45	-58.94	69.61	-24.31	-36.99	-13.69
Equity	39.31	39.31	39.31	39.31	0	39.31
OPM	22.14	13.60	9.94	8.40	12.04	9.75
Net Profit	409.36+128.2%	196.96	243.07	114.47	179.36	640.42
NPM	16.94	10.46	13.93	6.93	9.99	9.55
EPS	20.83+128.4%	10.02	12.37	5.82	9.12	32.58

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	6,651.38+10.3%	6,032.63+2.7%	5,874.06+14.1%	5,149+3.0%	4,996.61-1.1%	5,051.44
Other Income	55.90	47.88	31.32	3.55	49.98	9.73
Total Income	6,707.28+10.3%	6,080.51+3.0%	5,905.38+14.6%	5,152.54+2.1%	5,046.58-0.3%	5,061.17
Expenditure	-5,986.18-9.1%	-5,484.79-5.5%	-5,201.15-8.2%	-4,806.61-16.2%	-4,138.13-13.5%	-3,644.58
Interest	-86.51	-76.47	-54.47	-49	-16.67	-12.77
PBDT	0	0	0	0	0	0
EBITDA	1,062.71+17.9%	901.39-9.7%	998.52+50.3%	664.34-37.0%	1,054.46-32.9%	1,572.23
Depreciation	-311	-277.08	-271.14	-272.95	-179.31	-152.60
EBIT	751.71+20.4%	624.31-14.2%	727.38+85.8%	391.39-55.3%	875.15-38.4%	1,419.63
PBT	654.11+7.5%	608.59-13.6%	704.23+103.6%	345.93-61.9%	908.45-35.9%	1,416.59
Tax	-13.69	-105.47	-37.75	0.80	-114.45	-241.20
Equity	39.31	39.31	0	0	0	0
OPM (%)	9.75	10.01	12.00	7.00	18.00	28.00
Net Profit	640.42+27.3%	503.12-24.5%	666.48+92.2%	346.73-56.3%	794-32.4%	1,175.39
NPM (%)	9.55	8.27	11.00	7.00	16.00	23.00
EPS (Rs)	32.58+27.3%	25.60-24.5%	33.91+92.2%	17.64-56.3%	40.39-33.4%	60.67
CEPS	32.58	25.60	33.91	17.64	40.39	60.67

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	2,603.48+36.3%	2,149.77	1,847.72	1,876.31	1,910.15	7,344.90
Other Income	15.11	14.93	25.50	15.50	6.91	54.41
Total Income	2,618.59+36.6%	2,164.70	1,873.22	1,891.81	1,917.06	7,399.31
Interest	38.26	27.61	22.56	23.31	24.23	93.63
Expenditure	-2,179.28-28.6%	-1,943.23	-1,730.94	-1,686.24	-1,694.76	-6,638.62
PBDT	0	0	0	0	0	0
EBITDA	563.26+78.4%	331.86	227.92	293.50	315.69	1,118.46
Depreciation	-100.80	-97.71	-88.58	-80.12	-76.07	-318.55
EBIT	462.46+93.0%	234.15	139.34	213.38	239.62	799.91
PBT	439.31+97.6%	221.47	117.52	163.34	222.30	693.71
Tax	-104.05	-49.50	82.91	-29.55	-40	-23.12
Equity	39.31	39.31	39.31	0	0	39.31
OPM	16.78	10.23	6.27	8.63	11.60	9.38
Net Profit	333.91+81.8%	172.36	201.54	131.95	183.71	670.83
NPM	12.75	7.96	10.76	6.97	9.58	9.07
EPS	17.05+81.4%	8.80	10.31	6.76	9.40	34.33

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	7,344.90+10.1%	6,672.08+7.1%	6,228.63+10.2%	5,652.62+6.5%	5,305.79-1.6%	5,393.13
Other Income	54.41	42.55	28.31	2.74	50.46	10.02
Total Income	7,399.31+10.2%	6,714.63+7.3%	6,256.93+10.6%	5,655.36+5.6%	5,356.25-0.9%	5,403.15
Expenditure	-6,638.62-10.3%	-6,021.20-7.1%	-5,624.13-6.7%	-5,269.86-11.3%	-4,736.14-17.4%	-4,035.06
Interest	-93.63	-78.77	-56.19	-50.17	-17.73	-16.02
PBDT	0	0	0	0	0	0
EBITDA	1,118.46+10.9%	1,008.23+8.0%	933.36+31.8%	708.36-19.0%	874.16-43.9%	1,557.56
Depreciation	-318.55	-278.58	-272.67	-275.43	-286.78	-183.47
EBIT	799.91+9.6%	729.65+10.4%	660.69+52.6%	432.93-26.3%	587.38-57.3%	1,374.09
PBT	693.71-1.8%	706.30+11.6%	632.81+64.1%	385.51-37.8%	620.11-54.7%	1,368.09
Tax	-23.12	-125.16	-16.01	-12.60	-104.46	-253.31
Equity	39.31	39.31	0	0	0	0
OPM (%)	9.38	10.52	10.11	6.82	11.58	25.32
Net Profit	670.83+15.3%	582.01-5.5%	615.82+80.1%	341.99-34.4%	520.94-54.6%	1,146.52
NPM (%)	9.07	8.67	9.84	6.05	9.73	21.22
EPS (Rs)	34.33+15.7%	29.68-5.3%	31.33+80.1%	17.40-37.3%	27.76-54.3%	60.81
CEPS	34.33	29.68	31.33	17.40	27.76	60.81

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	12	29 Jul 2026
2025	Final Dividend	11	29 Jul 2025
2024	Final Dividend	11	15 Jul 2024
2023	Final Dividend	8	28 Jul 2023
2023	Interim Dividend	10	17 Aug 2022
2021	Final Dividend	14	19 Jul 2021
2020	Interim Dividend	7	16 Mar 2020
2020	Special Dividend	3	16 Mar 2020
2019	Final Dividend	5.5	18 Jul 2019
2018	Final Dividend	4	18 Jul 2018
2017	Final Dividend	4	11 Jul 2017
2016	Final Dividend	4	20 Jul 2016
2015	Final Dividend	3.5	22 Jul 2015
2014	Final Dividend	3	17 Jul 2014
2013	Final Dividend	2.5	29 Jul 2013
2012	Final Dividend	1.4	31 Jul 2012

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split